Section 1 Short title
This Act may be cited as the “Medical Supplies for Pandemics Act of 2021”.
Medical Supplies for Pandemics Act of 2021
A BILL
To amend the Public Health Service Act to authorize the use of the Strategic National Stockpile to enhance domestic medical supply chain elasticity and establish and maintain domestic reserves of critical medical supplies, and for other purposes.
Sec. 2 Supply chain flexibility manufacturing pilot
In general— Section 319F–2(a)(3) of the Public Health Service Act (42 U.S.C. 247d–6b(a)(3)) is amended—
in subparagraph (I), by striking “and” at the end;
in subparagraph (J), by striking the period at the end and inserting “; and”; and
by adding at the end the following new subparagraph:
“(K) enhance domestic medical supply chain elasticity and establish and maintain domestic reserves of critical medical supplies (including personal protective equipment, ancillary medical supplies, testing supplies, and other applicable supplies required for the administration of drugs, vaccines and other biological products, medical devices, and diagnostic tests) by—
“(i) creating incentives for the domestic manufacturing of medical supplies—
“(I) to increase emergency stock of critical medical supplies; and
“(II) to geographically diversify production of such supplies;
“(ii) purchasing, leasing, or entering into joint industrial-based expansion ventures with respect to, facilities and equipment for the production of medical supplies; and
“(iii) working with distributors of medical supplies to manage the domestic reserves established under this subparagraph by refreshing and replenishing stock of critical medical supplies.”
Reporting; sunset— Section 319F–2(a) of the Public Health Service Act (42 U.S.C. 247d–6b(a)) is amended by adding at the end the following:
“(6) Reporting—Not later than September 30, 2022, the Secretary shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a report on the details of each purchase, lease, or joint industrial-based expansion venture entered into under paragraph (3)(K), including the amount expended by the Secretary on each such purchase, lease, or joint venture.
“(7) Sunset—The authority to make purchases, leases, or joint ventures pursuant to paragraph (3)(K) shall cease to be effective on September 30, 2024.”
Funding— Section 319F–2(f) of the Public Health Service Act (42 U.S.C. 247d–6b(f)) is amended by adding at the end the following:
“(3) Supply chain elasticity
“(A) In general—For the purpose of carrying out subsection (a)(3)(K), there is authorized to be appropriated $500,000,000 for each of fiscal years 2021 through 2024, to remain available until expended.
“(B) Relation to other amounts—The amount authorized to be appropriated by subparagraph (A) for the purpose of carrying out subsection (a)(3)(K) is in addition to any other amounts available for such purpose.”